Objetivo
SaveMe project will address current urgent needs for pancreatic cancer diagnosis and treatment by exploiting partners’ expertise and most recent research achievements for the design and development of novel modular nanosystems platform integrating new functionalized nano-core particles and active agents. The modular platform will enable the design of diverse active nanosystems per diagnostic or therapeutic application as defined by their active agent compositions. For diagnostics, superior tracers will be developed for molecular MR/PET and gamma camera imaging, enabling efficient diagnosis and guided surgery respectively. Novel functionalized nano-core systems will be conjugated with semi-confluent active shell layer. Three types of shell layers will be design: (1) novel iron oxide nanoparticles as advanced MRI contrast agents and/or (2) DOTA complexes for MRI (with Gd3+), or PET (with Ga-68), or gamma camera (with Ga-69); (3) Integrating within one tracer both iron oxide nanoparticles and DOTA-Ga-68 complexes for a sequential or simultaneous MR/PET imaging. For therapeutics, active nanosystems will be developed to deliver (1) therapeutic siRNAs or (2) anti-MP-inhibitory-scFVs. These non-classic anti-tumor drugs will be designed based on an extensive tumor degradome analysis for combining blockage of selective matrix MPs, thus preventing basic invasive and metastasis steps, with siRNA based neutralization of secondary molecular effects induced by the specific protease inhibition. Individualized degradome analysis will be developed for potential profiling of anti-MP and siRNAs based therapy per patient. To facilitate the above diagnostics and therapeutic effects, advanced tumor targeting and penetration active agents will be linked to nano-core functionalized groups, including a biocompatible PEG layer linked to tumor selective MMP substrate molecules and highly safe and potent novel somatostatin analogue peptides targeting SSTR overexpression.
Ámbito científico
- medical and health sciencesclinical medicinesurgery
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- medical and health sciencesclinical medicineradiologynuclear medicine
- engineering and technologynanotechnologynano-materials
- medical and health sciencesclinical medicineoncologypancreatic cancer
Convocatoria de propuestas
FP7-NMP-2010-LARGE-4
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
69978 Tel Aviv
Israel
Ver en el mapa
Participantes (22)
1160 WIEN
Ver en el mapa
69120 Heidelberg
Ver en el mapa
52900 Ramat Gan
Ver en el mapa
40126 Bologna
Ver en el mapa
60323 Frankfurt Am Main
Ver en el mapa
115193 MOSKVA
Ver en el mapa
20014 San Sebastian
Ver en el mapa
20009 San Sebastian
Ver en el mapa
La participación finalizó
50059 SOVIGLIANA VINCI
Ver en el mapa
52621 Ramat Gan
Ver en el mapa
NR4 7TJ Norwich
Ver en el mapa
81675 Muenchen
Ver en el mapa
3000 Leuven
Ver en el mapa
7610001 Rehovot
Ver en el mapa
117997 MOSCOW
Ver en el mapa
La participación finalizó
W13 0BY London
Ver en el mapa
20139 MILANO MI
Ver en el mapa
La participación finalizó
752 28 Uppsala
Ver en el mapa
7608665 Rehovot
Ver en el mapa
75183 UPPSALA
Ver en el mapa
SO15 2BG SOUTHAMPTON
Ver en el mapa
50053 Sovigliana
Ver en el mapa